We thank the PREDICT-HD sites, the study participants, the National Research Roster for Huntington Disease Patients and Families, the Huntington’s Disease Society of America and the Huntington Study Group. This research was supported by the National Center for Advancing Translational Sciences, and the National Institutes of Health (NIH), through Grant 2 UL1 TR000442-06. This research is supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke (NS040068), CHDI Foundation, Inc (A3917), Cognitive and Functional Brain Changes in Preclinical Huntington’s Disease (HD) (5R01NS054893), 4D Shape Analysis for Modeling Spatiotemporal Change Trajectories in Huntington’s (1U01NS082086), Functional Connectiv...
The Functional Rating Scale Taskforce for pre-Huntington Disease (FuRST-pHD) is a multinational, mul...
Huntington’s disease (HD) is a neurodegenerative movement disorder caused by abnormal cytosine-adeni...
Background Huntington’s disease (HD) is a life-limiting neurodegenerative condition in which the on...
ACKNOWLEDGEMENTS We thank the PREDICT-HD sites, the study participants, the National Research Roster...
Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome m...
Objective: To identify an improved measure of clinical progression in early Huntington disease (HD) ...
Objectives: Huntington’s disease (HD) is a profoundly incapacitating, and ultimately fatal, neurodeg...
PURPOSE: Cognitive functioning impacts health-related quality of life (HRQOL) for individuals with H...
Altres ajuts: acord transformatiu CRUE-CSICBackground: Patients with Huntington's disease (HD) exhib...
Background: Huntington disease (HD) is a genetic neurodegenerative disease leading to progressive mo...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
Huntington’s disease (HD) is characterised by a triad of cognitive, behavioural, and motor symptoms...
BackgroundCognitive decline in Huntington’s disease (HD) begins early in the disease course, however...
BACKGROUND: Huntington's disease (HD) is an autosomal dominant, fully penetrant, neurodegenerative d...
Huntington’s disease (HD) is a progressive, non-curative, autosomal dominant neurodegenerative disea...
The Functional Rating Scale Taskforce for pre-Huntington Disease (FuRST-pHD) is a multinational, mul...
Huntington’s disease (HD) is a neurodegenerative movement disorder caused by abnormal cytosine-adeni...
Background Huntington’s disease (HD) is a life-limiting neurodegenerative condition in which the on...
ACKNOWLEDGEMENTS We thank the PREDICT-HD sites, the study participants, the National Research Roster...
Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome m...
Objective: To identify an improved measure of clinical progression in early Huntington disease (HD) ...
Objectives: Huntington’s disease (HD) is a profoundly incapacitating, and ultimately fatal, neurodeg...
PURPOSE: Cognitive functioning impacts health-related quality of life (HRQOL) for individuals with H...
Altres ajuts: acord transformatiu CRUE-CSICBackground: Patients with Huntington's disease (HD) exhib...
Background: Huntington disease (HD) is a genetic neurodegenerative disease leading to progressive mo...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
Huntington’s disease (HD) is characterised by a triad of cognitive, behavioural, and motor symptoms...
BackgroundCognitive decline in Huntington’s disease (HD) begins early in the disease course, however...
BACKGROUND: Huntington's disease (HD) is an autosomal dominant, fully penetrant, neurodegenerative d...
Huntington’s disease (HD) is a progressive, non-curative, autosomal dominant neurodegenerative disea...
The Functional Rating Scale Taskforce for pre-Huntington Disease (FuRST-pHD) is a multinational, mul...
Huntington’s disease (HD) is a neurodegenerative movement disorder caused by abnormal cytosine-adeni...
Background Huntington’s disease (HD) is a life-limiting neurodegenerative condition in which the on...